Leader
|
|
|
00000cz a2200037n 45 0 |
001
|
|
|
SELIBR|218606
(VIAF cluster)
(Authority/Source Record)
|
005
|
|
|
20180326123054.0 |
008
|
|
|
030514||||c|||aa|| || ||| |d |
003
|
|
|
SELIBR |
035
|
|
|
‡a
(SELIBR)218606
|
024
|
8 |
|
‡a
63980480
‡2
viaf
|
024
|
8 |
|
‡a
0000000051845223
‡2
isni
|
040
|
|
|
‡a
Uas
‡b
swe
|
043
|
|
|
‡a
e-sw---
|
100
|
1 |
|
‡a
James, Stefan,
‡d
1964-
|
670
|
|
|
‡a
James, Stefan. Coagulation, inflammation and myocardial dysfunction in unstable coronary artery disease and the influence of glycoprotein IIb/IIIa inhibition and low molecular weight heparin, 2003:
‡b
t.p. (Stefan James)
|
678
|
|
|
‡a
Läkare
|
887
|
|
|
‡a
{"@id":"b8nqsxqv4xs6zw8","modified":"2018-03-26T12:30:54+02:00","checksum":"4952134117"}
‡2
librisxl
|
901
|
|
|
‡a
978915131096
‡9
1
|
901
|
|
|
‡a
978915545580
‡9
1
|
909
|
|
|
‡a
(viaf) 63980480
‡9
1
|
909
|
|
|
‡a
(isni) 0000000051845223
‡9
1
|
909
|
|
|
‡a
(librisxl) b8nqsxqv4xs6zw8
‡9
1
|
910
|
|
|
‡a
benchmarkingobservationalanalysesbeforeusingthemtoaddressquestionstrialsdonotansweranapplicationtocoronarythrombusaspiration
‡A
Benchmarking Observational Analyses Before Using Them to Address Questions Trials Do Not Answer
‡b
An Application to Coronary Thrombus Aspiration.
‡l
eng
‡9
1
|
910
|
|
|
‡a
assessingtheexternalvalidityofthevalidateswedehearttrial
‡A
Assessing the external validity of the VALIDATE-SWEDEHEART trial
‡l
eng
‡9
1
|
910
|
|
|
‡a
patientexperienceoftheinformedconsentprocessduringacutemyocardialinfarctionasubstudyofthevalidateswedehearttrial
‡A
Patient experience of the informed consent process during acute myocardial infarction
‡b
a sub-study of the VALIDATE-SWEDEHEART trial.
‡l
eng
‡9
1
|
910
|
|
|
‡a
associationofmodeoflocationactivityandmobilitywithacutecoronarysyndromenationwideecologicalstudy
‡A
The association of mode of location activity and mobility with acute coronary syndrome
‡b
nationwide ecological study.
‡l
eng
‡9
1
|
910
|
|
|
‡a
associationofchromosome9p21withsubsequentcoronaryheartdiseaseeventsageniuschdstudyofindividualparticipantdata
‡A
Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events
‡b
A GENIUS-CHD Study of Individual Participant Data.
‡l
eng
‡9
1
|
910
|
|
|
‡a
minimumcoredataelementsforevaluationoftavrascientificstatementbypassion105hvcandtvtregistry
‡A
Minimum Core Data Elements for Evaluation of TAVR
‡b
A Scientific Statement by PASSION CV, HVC, and TVT Registry.
‡l
eng
‡9
1
|
910
|
|
|
‡a
acutestrokeortransientischemicattacktreatedwithticagrelorandaspirinforpreventionofstrokeanddeaththalestrialrationaleanddesign
‡A
The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial
‡b
Rationale and design.
‡l
eng
‡9
1
|
910
|
|
|
‡a
physicalactivityreducesepilepsyincidencearetrospectivecohortstudyinswedishcrosscountryskiersandanexperimentalstudyinseizurepronesynapsin2knockoutmice
‡A
Physical Activity Reduces Epilepsy Incidence
‡b
a Retrospective Cohort Study in Swedish Cross-Country Skiers and an Experimental Study in Seizure-Prone Synapsin II Knockout Mice.
‡l
eng
‡9
1
|
910
|
|
|
‡a
onthenaturalhistoryofcoronaryarterydiseasealongitudinalnationwideserialangiographystudy
‡A
On the Natural History of Coronary Artery Disease
‡b
A Longitudinal Nationwide Serial Angiography Study.
‡l
eng
‡9
1
|
910
|
|
|
‡a
ischemicbenefitandhemorrhageriskofticagreloraspirinversusaspirininpatientswithacuteischemicstrokeortransientischemicattack
‡A
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack
‡l
eng
‡9
1
|
910
|
|
|
‡a
rationaleanddesignofthedapa1001trialdapagliflozininpatientswithoutdiabetesmellituswithacutemyocardialinfarction
‡A
Rationale and design of the DAPA-MI trial
‡b
Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction.
‡l
eng
‡9
1
|
910
|
|
|
‡a
associationsofpolymorphismsintheperoxisomeproliferatoractivatedreceptorgammacoactivator1alphagenewithsubsequentcoronaryheartdiseaseanindividuallevelmetaanalysis
‡A
Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease
‡b
An Individual-Level Meta-Analysis.
‡l
eng
‡9
1
|
910
|
|
|
‡a
designandrationaleofthemyocardialinfarctionandnewtreatmentwithmetforminstudymimetstudyprotocolforaregistrybasedrandomisedclinicaltrial
‡A
Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial
‡l
eng
‡9
1
|
910
|
|
|
‡a
prevalenceandrelevanceofabnormalglucosemetabolisminacutecoronarysyndromesinsightsfromtheplateletinhibitionandpatientoutcomesplatotrial
‡A
Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes
‡b
insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
‡l
eng
‡9
1
|
910
|
|
|
‡a
invasivetreatmentofcoronaryarterydiseaseaspectsonantithromboticandpercutaneoustreatmentoptions
‡A
Invasive treatment of coronary artery disease
‡b
[em]Aspects on antithrombotic and percutaneous treatment options[/em].
‡l
eng
‡9
1
|
910
|
|
|
‡a
factor5leidendoesnotmodifythephenotypeofacutecoronarysyndromeortheextentofmyocardialnecrosis
‡A
Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis
‡l
eng
‡9
1
|
910
|
|
|
‡a
myocardialinfarctionafterelectivepercutaneouscoronaryinterventionwhichcardiactroponincutofftouse
‡A
Myocardial infarction after elective percutaneous coronary intervention-which cardiac troponin cut-off to use?
‡l
eng
‡9
1
|
910
|
|
|
‡a
midlifephysicalactivityisassociatedwithlowerincidenceofvasculardementiabutnotalzheimersdisease
‡A
Midlife physical activity is associated with lower incidence of vascular dementia but not Alzheimer's disease
‡l
eng
‡9
1
|
910
|
|
|
‡a
timecourseforbenefitandriskofticagrelorandaspirininacuteischemicstrokeortransientischemicattack
‡A
Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack
‡l
eng
‡9
1
|
910
|
|
|
‡a
clinicaloutcomesaftersurgicalrevascularizationusingnotouchversusconventionalsaphenousveingraftsmidtermfollowupofpropensityscorematchedcohorts
‡A
Clinical Outcomes After Surgical Revascularization Using No-Touch Versus Conventional Saphenous Vein Grafts
‡b
Mid-Term Follow-Up of Propensity Score Matched Cohorts.
‡l
eng
‡9
1
|
910
|
|
|
‡a
publicsperspectiveoncardiovascularriskinformationimplicationsforpractice
‡A
The publics' perspective on cardiovascular risk information
‡b
Implications for practice.
‡l
eng
‡9
1
|
910
|
|
|
‡a
coagulationinflammationandmyocardialdysfunctioninunstablecoronaryarterydiseaseandtheinfluenceofglycoproteiniibiiiainhibitionandlowmolecularweightheparin
‡A
Coagulation, inflammation and myocardial dysfunction in unstable coronary artery disease and the influence of glycoprotein IIb/IIIa inhibition and low molecular weight heparin /
‡l
eng
‡9
1
|
910
|
|
|
‡a
antithrombotictreatmentstrategiesinpatientswithestablishedcoronaryatheroscleroticdisease
‡A
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
‡l
eng
‡9
1
|
910
|
|
|
‡a
nationwidecardiovascularriskcategorizationapplyingtheeuropeansocietyofcardiologyescguidelinestotheswedishnationaldiabetesregister
‡A
Nationwide cardiovascular risk categorization
‡b
applying the European Society of Cardiology (ESC) guidelines to the Swedish National Diabetes Register.
‡l
eng
‡9
1
|
910
|
|
|
‡a
ticagreloraddedtoaspirininacuteischemicstrokeortransientischemicattackinpreventionofdisablingstrokearandomizedclinicaltrial
‡A
Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke
‡b
A Randomized Clinical Trial.
‡l
eng
‡9
1
|
910
|
|
|
‡a
surgicalremovalofadetachedmitralvalverepaircliptoresolvecardiogenicshock
‡A
Surgical Removal of a Detached Mitral Valve Repair Clip to Resolve Cardiogenic Shock
‡l
eng
‡9
1
|
910
|
|
|
‡a
coronaryangiographyafteroutofhospitalcardiacarrest
‡A
Coronary angiography after out-of-hospital cardiac arrest
‡l
eng
‡9
1
|
910
|
|
|
‡a
shorttermmentaldistressinresearchparticipantsafterreceivingcardiovascularriskinformation
‡A
Short-term mental distress in research participants after receiving cardiovascular risk information
‡l
eng
‡9
1
|
910
|
|
|
‡a
differentialeffectofclopidogrelandticagreloronleukocytecountinrelationtopatientcharacteristicsbiomarkersandgenotypeaplatosubstudy
‡A
Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype
‡b
a PLATO substudy.
‡l
eng
‡9
1
|
910
|
|
|
‡a
lowdoseticagrelorwithorwithoutacetylsalicylicacidinpatientswithacutecoronarysyndromerationaleanddesignoftheelectrasirio2trial
‡A
Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome
‡b
Rationale and design of the ELECTRA-SIRIO 2 trial.
‡l
eng
‡9
1
|
910
|
|
|
‡a
efficacyandsafetyofticagrelorandaspirininpatientswithmoderateischemicstrokeanexploratoryanalysisofthethalesrandomizedclinicaltrial
‡A
Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke
‡b
An Exploratory Analysis of the THALES Randomized Clinical Trial.
‡l
eng
‡9
1
|
910
|
|
|
‡a
costeffectivenessofticagrelorinpatientswithtype2diabetesandcoronaryarterydiseaseaeuropeaneconomicevaluationofthethemistrial
‡A
Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease
‡b
a European economic evaluation of the THEMIS trial.
‡l
eng
‡9
1
|
910
|
|
|
‡a
impactofthrombusaspirationonmortalitystentthrombosisandstrokeinpatientswithstsegmentelevationmyocardialinfarctionareportfromtheswedishcoronaryangiographyandangioplastyregistry
‡A
Impact of Thrombus Aspiration on Mortality, Stent Thrombosis, and Stroke in Patients With ST-Segment-Elevation Myocardial Infarction
‡b
a Report From the Swedish Coronary Angiography and Angioplasty Registry.
‡l
eng
‡9
1
|
910
|
|
|
‡a
10yearallcausedeathafterpercutaneousorsurgicalrevascularizationindiabeticpatientswithcomplexcoronaryarterydisease
‡A
Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease
‡l
eng
‡9
1
|
910
|
|
|
‡a
developmentandvalidationofanartificialneuralnetworkalgorithmtopredictmortalityandadmissiontohospitalforheartfailureaftermyocardialinfarctionanationwidepopulationbasedstudy
‡A
Development and validation of an artificial neural network algorithm to predict mortality and admission to hospital for heart failure after myocardial infarction
‡b
a nationwide population-based study.
‡l
eng
‡9
1
|
910
|
|
|
‡a
bleedingavoidancestrategiesinpercutaneouscoronaryintervention
‡A
Bleeding avoidance strategies in percutaneous coronary intervention
‡l
eng
‡9
1
|
910
|
|
|
‡a
subsequenteventriskinindividualswithestablishedcoronaryheartdiseasedesignandrationaleofthegeniuschdconsortium
‡A
Subsequent Event Risk in Individuals With Established Coronary Heart Disease
‡b
Design and Rationale of the GENIUS-CHD Consortium.
‡l
eng
‡9
1
|
910
|
|
|
‡a
delayedclinicalmanifestationofparkinsonsdiseaseamongphysicallyactivedoparticipantsinalongdistanceskiracehaveamotorreserve
‡A
Delayed Clinical Manifestation of Parkinson's Disease Among Physically Active
‡b
Do Participants in a Long-Distance Ski Race Have a Motor Reserve?.
‡l
eng
‡9
1
|
910
|
|
|
‡a
retrospectivenationwideanalysisofevolocumabuseinswedenanditseffectonlowdensitylipoproteincholesterollevels
‡A
A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levels
‡l
eng
‡9
1
|
910
|
|
|
‡a
postresuscitationmyocardialdysfunctioninoutofhospitalcardiacarrestpatientsrandomizedtoimmediatecoronaryangiographyversusstandardofcare
‡A
Post-resuscitation myocardial dysfunction in out-of-hospital cardiac arrest patients randomized to immediate coronary angiography versus standard of care
‡l
eng
‡9
1
|
910
|
|
|
‡a
shortandlongtermclinicaloutcomesforpatientswithtakotsubosyndromeandpatientswithmyocardialinfarctionareportfromtheswedishcoronaryangiographyandangioplastyregistry
‡A
Short- and Long-Term Clinical Outcomes for Patients With Takotsubo Syndrome and Patients With Myocardial Infarction
‡b
A Report From the Swedish Coronary Angiography and Angioplasty Registry.
‡l
eng
‡9
1
|
910
|
|
|
‡a
costeffectivenessofticagrelorplusaspirinversusaspirininacuteischaemicstrokeortransientischaemicattackaneconomicevaluationofthethalestrial
‡A
Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack
‡b
an economic evaluation of the THALES trial.
‡l
eng
‡9
1
|
910
|
|
|
‡a
patienttailoredantithrombotictherapyfollowingpercutaneouscoronaryintervention
‡A
Patient-tailored antithrombotic therapy following percutaneous coronary intervention
‡l
eng
‡9
1
|
910
|
|
|
‡a
lowdensitylipoproteincholesterolreductionandstatinintensityinmyocardialinfarctionpatientsandmajoradverseoutcomesaswedishnationwidecohortstudy
‡A
Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes
‡b
a Swedish nationwide cohort study.
‡l
eng
‡9
1
|
910
|
|
|
‡a
sexspecificaspectsonprognosisafteraorticvalvereplacementforaorticstenosisaswedeheartregistrystudy
‡A
Sex-specific aspects on prognosis after aortic valve replacement for aortic stenosis
‡b
a SWEDEHEART registry study.
‡l
eng
‡9
1
|
910
|
|
|
‡a
riskassessmentusingriskscoresinpatientswithacutecoronarysyndrome
‡A
Risk Assessment Using Risk Scores in Patients with Acute Coronary Syndrome
‡l
eng
‡9
1
|
910
|
|
|
‡a
admissionlevelsofdkk1dickkopf1areassociatedwithfuturecardiovasculardeathinpatientswithacutecoronarysyndromes
‡A
Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes
‡l
eng
‡9
1
|
910
|
|
|
‡a
sglt2inhibitorsforpatientswithtype2diabetesmellitusaftermyocardialinfarctionanationwideobservationregistrystudyfromswedeheart
‡A
SGLT2 inhibitors for patients with type 2 diabetes mellitus after myocardial infarction
‡b
a nationwide observation registry study from SWEDEHEART.
‡l
eng
‡9
1
|
910
|
|
|
‡a
impairedfibrinolysispredictsadverseoutcomeinacutecoronarysyndromepatientswithdiabetesaplatosubstudy
‡A
Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes
‡b
A PLATO Sub-Study.
‡l
eng
‡9
1
|
910
|
|
|
‡a
helicobacterpyloriscreeninginclinicalroutineduringhospitalizationforacutemyocardialinfarction
‡A
Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction
‡l
eng
‡9
1
|
910
|
|
|
‡a
communicatingtestresultsfromageneralhealthcheckpreferencesfromadiscretechoiceexperimentsurvey
‡A
Communicating Test Results from a General Health Check
‡b
Preferences from a Discrete Choice Experiment Survey.
‡l
eng
‡9
1
|
910
|
|
|
‡a
bivalirudinversusheparinmonotherapyinnonstsegmentelevationmyocardialinfarction
‡A
Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction
‡l
eng
‡9
1
|
910
|
|
|
‡a
physicallyactivelifestyleisassociatedwithlowerlongtermincidenceofbipolardisorderinapopulationbasedlargescalestudy
‡A
A physically active lifestyle is associated with lower long-term incidence of bipolar disorder in a population-based, large-scale study
‡l
eng
‡9
1
|
910
|
|
|
‡a
ticagreloraddedtoaspirininacutenonsevereischemicstrokeortransientischemicattackofatheroscleroticorigin
‡A
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin
‡l
eng
‡9
1
|
910
|
|
|
‡a
temporaltrendsintheprevalenceofcanceranditsimpactonoutcomeinpatientswith1myocardialinfarctionanationwidestudy
‡A
Temporal Trends in the Prevalence of Cancer and Its Impact on Outcome in Patients With First Myocardial Infarction
‡b
A Nationwide Study.
‡l
eng
‡9
1
|
910
|
|
|
‡a
prolongedantithrombotictherapyinpatientsafteracutecoronarysyndromeacriticalappraisalofcurrenteuropeansocietyofcardiologyguidelines
‡A
Prolonged antithrombotic therapy in patients after acute coronary syndrome
‡b
A critical appraisal of current European Society of Cardiology guidelines.
‡l
eng
‡9
1
|
910
|
|
|
‡a
impactofchronicobstructivepulmonarydiseaseon10yearmortalityafterpercutaneouscoronaryinterventionandbypasssurgeryforcomplexcoronaryarterydiseaseinsightsfromthesyntaxextendedsurvivalstudy
‡A
Impact of chronic obstructive pulmonary disease on 10-year mortality after percutaneous coronary intervention and bypass surgery for complex coronary artery disease
‡b
insights from the SYNTAX Extended Survival study.
‡l
eng
‡9
1
|
910
|
|
|
‡a
plasmaneurofilamentlightchainiselevatedaftertranscatheteraorticvalveimplantation
‡A
Plasma neurofilament light chain is elevated after transcatheter aortic valve implantation
‡l
eng
‡9
1
|
910
|
|
|
‡a
physicalactivityisassociatedwithlowerlongtermincidenceofanxietyinapopulationbasedlargescalestudy
‡A
Physical Activity Is Associated With Lower Long-Term Incidence of Anxiety in a Population-Based, Large-Scale Study
‡l
eng
‡9
1
|
910
|
|
|
‡a
clinicalimpactofintraproceduralstentthrombosisduringpercutaneouscoronaryinterventioninpatientstreatedwithpotentp2y12inhibitorsavalidateswedeheartsubstudy
‡A
Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors - a VALIDATE-SWEDEHEART Substudy
‡l
eng
‡9
1
|
910
|
|
|
‡a
factor5leidenandtheriskofbleedinginpatientswithacutecoronarysyndromestreatedwithantiplatelettherapypooledanalysisof3randomizedclinicaltrials
‡A
Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy
‡b
Pooled Analysis of 3 Randomized Clinical Trials.
‡l
eng
‡9
1
|
910
|
|
|
‡a
findingsoncoronaryangiographiesinpatientswithrheumatoidarthritisandischemicheartdiseasearetheydifferentfrompatientswithoutrheumatoidarthritis
‡A
Findings on coronary angiographies in patients with rheumatoid arthritis and ischemic heart disease
‡b
are they different from patients without rheumatoid arthritis?.
‡l
eng
‡9
1
|
910
|
|
|
‡a
goodgeneralhealthandlackoffamilyhistoryinfluencetheunderestimationofcardiovascularrisk
‡A
Good general health and lack of family history influence the underestimation of cardiovascular risk
‡b
A cross sectional study.
‡l
eng
‡9
1
|
910
|
|
|
‡a
analysisoflocalextracellularmatrixidentifiesdifferentaetiologiesbehindbicuspidandtricuspidaorticvalvedegenerationandsuggeststherapies
‡A
Analysis of local extracellular matrix identifies different aetiologies behind bicuspid and tricuspid aortic valve degeneration and suggests therapies
‡l
eng
‡9
1
|
910
|
|
|
‡a
qualityandutilityofeuropeancardiovascularandorthopaedicregistriesfortheregulatoryevaluationofmedicaldevicesafetyandperformanceacrosstheimplantlifecycle
‡A
Quality and Utility of European Cardiovascular and Orthopaedic Registries for the Regulatory Evaluation of Medical Device Safety and Performance Across the Implant Lifecycle
‡b
A Systematic Review.
‡l
eng
‡9
1
|
910
|
|
|
‡a
incomeisassociatedwiththeprobabilitytoreceiveearlycoronaryangiographyafteroutofhospitalcardiacarrest
‡A
Income is associated with the probability to receive early coronary angiography after out-of-hospital cardiac arrest
‡l
eng
‡9
1
|
910
|
|
|
‡a
patientsexperiencesofclinicaltrialparticipationinvolvingaproductremotelyassessingstudydrugadherence
‡A
Patients' experiences of clinical trial participation involving a product remotely assessing study drug adherence
‡l
eng
‡9
1
|
910
|
|
|
‡a
sexrelateddifferencesinthrombusburdeninstemipatientsundergoingprimarypercutaneouscoronaryintervention
‡A
Sex-Related Differences in Thrombus Burden in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention
‡l
eng
‡9
1
|
919
|
|
|
‡a
coagulationinflammationandmyocardialdysfunctioninunstablecoronaryarterydiseaseandtheinfluenceofglycoproteiniibiiiainhibitionandlowmolecularweightheparin
‡A
Coagulation, inflammation and myocardial dysfunction in unstable coronary artery disease and the influence of glycoprotein IIb/IIIa inhibition and low molecular weight heparin, 2003:
‡9
1
|
920
|
|
|
‡a
978-915
‡9
2
|
921
|
|
|
‡a
oxford university press oup
‡b
Oxford University Press (OUP),
‡9
3
|
921
|
|
|
‡a
sage publications
‡b
SAGE Publications,
‡9
1
|
921
|
|
|
‡a
bmc
‡b
BMC,
‡9
2
|
921
|
|
|
‡a
elsevier
‡b
Elsevier,
‡9
9
|
921
|
|
|
‡a
john wiley & sons
‡b
John Wiley & Sons,
‡9
1
|
921
|
|
|
‡a
springer
‡b
Springer,
‡9
3
|
921
|
|
|
‡a
ovid technologies wolters kluwer health
‡b
Ovid Technologies (Wolters Kluwer Health),
‡9
3
|
921
|
|
|
‡a
frontiers media sa
‡b
Frontiers Media SA,
‡9
2
|
921
|
|
|
‡a
acta universitatis upsaliensis
‡b
Acta Universitatis Upsaliensis,
‡9
3
|
921
|
|
|
‡a
wiley
‡b
WILEY,
‡9
4
|
921
|
|
|
‡a
wolters kluwer
‡b
Wolters Kluwer,
‡9
1
|
921
|
|
|
‡a
elsevier bv
‡b
Elsevier BV,
‡9
1
|
921
|
|
|
‡a
acta universitatis upsaliensis univ bibl
‡b
Acta Universitatis Upsaliensis :
‡b
Univ.-bibl. [distributör],
‡9
1
|
921
|
|
|
‡a
oxford university press
‡b
Oxford University Press,
‡9
3
|
921
|
|
|
‡a
public library science
‡b
PUBLIC LIBRARY Science,
‡9
1
|
921
|
|
|
‡a
taylor & francis
‡b
Taylor & Francis,
‡9
1
|
921
|
|
|
‡a
vm media sp zo o vm group sk
‡b
VM Media SP. zo.o VM Group SK,
‡9
2
|
921
|
|
|
‡a
american medical association ama
‡b
American Medical Association (AMA),
‡9
1
|
921
|
|
|
‡a
springer nature
‡b
Springer Nature,
‡9
4
|
921
|
|
|
‡a
ios press
‡b
IOS Press,
‡9
1
|
921
|
|
|
‡a
upsala medical society
‡b
Upsala Medical Society,
‡9
1
|
921
|
|
|
‡a
elsevier ireland ltd
‡b
ELSEVIER IRELAND LTD,
‡9
1
|
921
|
|
|
‡a
bmj
‡b
BMJ,
‡9
1
|
921
|
|
|
‡a
oxford univ press
‡b
OXFORD UNIV PRESS,
‡9
1
|
921
|
|
|
‡a
bmj publishing group ltd
‡b
BMJ Publishing Group Ltd,
‡9
1
|
921
|
|
|
‡a
mdpi
‡b
MDPI,
‡9
1
|
921
|
|
|
‡a
georg thieme verlag kg
‡b
GEORG THIEME Verlag KG,
‡9
1
|
921
|
|
|
‡a
s karger
‡b
S. Karger,
‡9
1
|
921
|
|
|
‡a
kerman university of medical sciences
‡b
Kerman University of Medical Sciences,
‡9
1
|
922
|
|
|
‡a
sw
‡b
se
‡9
64
|
922
|
|
|
‡a
xx
‡9
4
|
930
|
|
|
‡a
stefan james
‡c
by Stefan James.
‡9
1
|
940
|
|
|
‡a
eng
‡9
73
|
941
|
|
|
‡a
aut
‡4
aut
‡9
43
|
941
|
|
|
‡a
author
‡4
author
‡9
7
|
941
|
|
|
‡a
thesisadvisor
‡4
thesisAdvisor
‡9
2
|
943
|
|
|
‡a
200x
‡A
2003
‡9
2
|
943
|
|
|
‡a
201x
‡9
10
|
944
|
|
|
‡a
aa
‡9
64
|
944
|
|
|
‡a
am
‡9
4
|
947
|
|
|
‡a
SE
‡9
1
|
950
|
|
|
‡a
erlinge david
‡A
Erlinge, David.
‡9
13
|
950
|
|
|
‡a
himmelmann anders
‡A
Himmelmann, Anders
‡9
12
|
950
|
|
|
‡a
jernberg tomas
‡A
Jernberg, Tomas.
‡9
9
|
950
|
|
|
‡a
frobert ole
‡A
Fröbert, Ole.
‡9
9
|
950
|
|
|
‡a
wallentin lars
‡A
Wallentin, Lars,
‡d
1943
‡9
8
|
950
|
|
|
‡a
siegbahn agneta
‡A
Siegbahn, Agneta,
‡d
1947
‡9
8
|
950
|
|
|
‡a
hagstrom emil
‡A
Hagström, Emil
‡9
7
|
950
|
|
|
‡a
wang yongjun
‡A
Wang, Yongjun
‡9
7
|
950
|
|
|
‡a
molina carlos a
‡A
Molina, Carlos A
‡9
7
|
950
|
|
|
‡a
ladenvall per
‡A
Ladenvall, Per
‡9
7
|
950
|
|
|
‡a
evans scott r
‡A
Evans, Scott R
‡9
7
|
950
|
|
|
‡a
denison hans
‡A
Denison, Hans
‡9
7
|
950
|
|
|
‡a
amarenco pierre
‡A
Amarenco, Pierre
‡9
7
|
950
|
|
|
‡a
johnston s claiborne
‡A
Johnston, S. Claiborne
‡9
7
|
950
|
|
|
‡a
omerovic elmir
‡A
Omerovic, Elmir.
‡9
6
|
950
|
|
|
‡a
koul sasha
‡A
Koul, Sasha.
‡9
6
|
950
|
|
|
‡a
knutsson mikael
‡A
Knutsson, Mikael
‡9
6
|
950
|
|
|
‡a
storey robert f
‡A
Storey, Robert F.
‡9
6
|
950
|
|
|
‡a
akerblom axel
‡A
Åkerblom, Axel,
‡d
1977
‡9
5
|
950
|
|
|
‡a
eriksson niclas
‡A
Eriksson, Niclas,
‡d
1978
‡9
5
|
950
|
|
|
‡a
ten berg jurrien m
‡A
Ten Berg, Jurrien M
‡9
5
|
950
|
|
|
‡a
hallmarker ulf
‡A
Hållmarker, Ulf,
‡d
1946
‡9
5
|
950
|
|
|
‡a
deierborg tomas
‡A
Deierborg, Tomas
‡9
5
|
950
|
|
|
‡a
lindahl bertil
‡A
Lindahl, Bertil,
‡d
1957-
‡9
4
|
950
|
|
|
‡a
held claes
‡A
Held, Claes,
‡d
1956-
‡9
4
|
950
|
|
|
‡a
lagerqvist bo
‡A
Lagerqvist, Bo,
‡d
1952
‡9
4
|
950
|
|
|
‡a
asselbergs folkert w
‡A
Asselbergs, Folkert W
‡9
4
|
950
|
|
|
‡a
mohammad moman a
‡A
Mohammad, Moman A.
‡9
4
|
950
|
|
|
‡a
oldgren jonas
‡A
Oldgren, Jonas,
‡d
1964-
‡9
4
|
950
|
|
|
‡a
svensson martina
‡A
Svensson, Martina
‡9
4
|
950
|
|
|
‡a
grauman asa
‡A
Grauman, Åsa,
‡d
1982-
‡9
4
|
950
|
|
|
‡a
hansson mats g
‡A
Hansson, Mats G.,
‡d
1952-
‡9
4
|
950
|
|
|
‡a
veldwijk jorien
‡A
Veldwijk, Jorien.
‡9
4
|
950
|
|
|
‡a
buccheri sergio
‡A
Buccheri, Sergio.
‡9
4
|
950
|
|
|
‡a
lang chim c
‡A
Lang, Chim C
‡9
3
|
950
|
|
|
‡a
pare guillaume
‡A
Pare, Guillaume
‡9
3
|
950
|
|
|
‡a
patel riyaz s
‡A
Patel, Riyaz S
‡9
3
|
950
|
|
|
‡a
tragante vinicius
‡A
Tragante, Vinicius
‡9
3
|
950
|
|
|
‡a
leander karin
‡A
Leander, Karin
‡9
3
|
950
|
|
|
‡a
allayee hooman
‡A
Allayee, Hooman
‡9
3
|
950
|
|
|
‡a
foco luisa
‡A
Foco, Luisa
‡9
3
|
950
|
|
|
‡a
gijsberts crystel m
‡A
Gijsberts, Crystel M
‡9
3
|
950
|
|
|
‡a
gong yan
‡A
Gong, Yan
‡9
3
|
950
|
|
|
‡a
kuukasjarvi pekka
‡A
Kuukasjarvi, Pekka
‡9
3
|
950
|
|
|
‡a
leiherer andreas
‡A
Leiherer, Andreas
‡9
3
|
950
|
|
|
‡a
lyytikainen leo pekka
‡A
Lyytikainen, Leo-Pekka
‡9
3
|
950
|
|
|
‡a
nikus kjell
‡A
Nikus, Kjell
‡9
3
|
950
|
|
|
‡a
tang w h wilson
‡A
Tang, W. H. Wilson
‡9
3
|
950
|
|
|
‡a
trompet stella
‡A
Trompet, Stella
‡9
3
|
950
|
|
|
‡a
van der laan sander w
‡A
Van der Laan, Sander W
‡9
3
|
950
|
|
|
‡a
van setten jessica
‡A
Van Setten, Jessica
‡9
3
|
950
|
|
|
‡a
casu gavino
‡A
Casu, Gavino
‡9
3
|
950
|
|
|
‡a
deanfield john
‡A
Deanfield, John
‡9
3
|
950
|
|
|
‡a
gigante bruna
‡A
Gigante, Bruna
‡9
3
|
950
|
|
|
‡a
marziliano nicola
‡A
Marziliano, Nicola
‡9
3
|
950
|
|
|
‡a
mordi ify r
‡A
Mordi, Ify R
‡9
3
|
950
|
|
|
‡a
saely christoph h
‡A
Saely, Christoph H
‡9
3
|
950
|
|
|
‡a
algra ale
‡A
Algra, Ale
‡9
3
|
950
|
|
|
‡a
burkhardt ralph
‡A
Burkhardt, Ralph
‡9
3
|
950
|
|
|
‡a
cooper dehoff rhonda m
‡A
Cooper-DeHoff, Rhonda M
‡9
3
|
950
|
|
|
‡a
cresci sharon
‡A
Cresci, Sharon
‡9
3
|
950
|
|
|
‡a
de faire ulf
‡A
De Faire, Ulf
‡9
3
|
950
|
|
|
‡a
doughty robert n
‡A
Doughty, Robert N
‡9
3
|
950
|
|
|
‡a
drexel heinz
‡A
Drexel, Heinz
‡9
3
|
950
|
|
|
‡a
fox keith a a
‡A
Fox, Keith A. A
‡9
3
|
950
|
|
|
‡a
hazen stanley l
‡A
Hazen, Stanley L
‡9
3
|
950
|
|
|
‡a
johnson julie a
‡A
Johnson, Julie A
‡9
3
|
950
|
|
|
‡a
jukema j wouter
‡A
Jukema, J. Wouter
‡9
3
|
950
|
|
|
‡a
kahonen mika
‡A
Kahonen, Mika
‡9
3
|
950
|
|
|
‡a
laurikka jari o
‡A
Laurikka, Jari O
‡9
3
|
950
|
|
|
‡a
lehtimaki terho
‡A
Lehtimaki, Terho
‡9
3
|
950
|
|
|
‡a
mahmoodi bakhtawar k
‡A
Mahmoodi, Bakhtawar K
‡9
3
|
950
|
|
|
‡a
maitland van der zee anke h
‡A
Maitland-van der Zee, Anke H
‡9
3
|
950
|
|
|
‡a
pepine carl j
‡A
Pepine, Carl J
‡9
3
|
950
|
|
|
‡a
gale chris p
‡A
Gale, Chris P.
‡9
3
|
950
|
|
|
‡a
scholz markus
‡A
Scholz, Markus
‡9
3
|
950
|
|
|
‡a
sinisalo juha
‡A
Sinisalo, Juha
‡9
3
|
950
|
|
|
‡a
spertus john a
‡A
Spertus, John A
‡9
3
|
950
|
|
|
‡a
horne benjamin d
‡A
Horne, Benjamin D
‡9
3
|
950
|
|
|
‡a
ridderstrale wilhelm
‡A
Ridderstrale, Wilhelm.
‡9
3
|
950
|
|
|
‡a
steg philippe gabriel
‡A
Steg, Philippe Gabriel.
‡9
3
|
950
|
|
|
‡a
budaj andrzej
‡A
Budaj, Andrzej.
‡9
3
|
950
|
|
|
‡a
becker richard c
‡A
Becker, Richard C.
‡9
3
|
950
|
|
|
‡a
valgimigli marco
‡A
Valgimigli, Marco.
‡9
3
|
950
|
|
|
‡a
windecker stephan
‡A
Windecker, Stephan.
‡9
3
|
950
|
|
|
‡a
lagedal rickard
‡A
Lagedal, Rickard,
‡d
1981-
‡9
3
|
950
|
|
|
‡a
rubertsson sten
‡A
Rubertsson, Sten.
‡9
3
|
950
|
|
|
‡a
angeras oskar
‡A
Angeras, Oskar.
‡9
3
|
950
|
|
|
‡a
petursson petur
‡A
Petursson, Petur.
‡9
3
|
950
|
|
|
‡a
sarno giovanna
‡A
Sarno, Giovanna.
‡9
3
|
950
|
|
|
‡a
hofmann robin
‡A
Hofmann, Robin.
‡9
3
|
950
|
|
|
‡a
olsson anneli
‡A
Olsson, Anneli
‡9
2
|
950
|
|
|
‡a
rylance rebecca
‡A
Rylance, Rebecca
‡9
2
|
950
|
|
|
‡a
waltenberger johannes
‡A
Waltenberger, Johannes
‡9
2
|
950
|
|
|
‡a
tardif jean claude
‡A
Tardif, Jean-Claude
‡9
2
|
950
|
|
|
‡a
cameron vicky a
‡A
Cameron, Vicky A
‡9
2
|
950
|
|
|
‡a
sattar naveed
‡A
Sattar, Naveed
‡9
2
|
950
|
|
|
‡a
brophy james m
‡A
Brophy, James M
‡9
2
|
950
|
|
|
‡a
anderson jeffrey l
‡A
Anderson, Jeffrey L
‡9
2
|
950
|
|
|
‡a
schmidt amand f
‡A
Schmidt, Amand F
‡9
2
|
950
|
|
|
‡a
mccubrey raymond o
‡A
McCubrey, Raymond O
‡9
2
|
950
|
|
|
‡a
holmes michael
‡A
Holmes, Michael
‡9
2
|
950
|
|
|
‡a
howe laurence j
‡A
Howe, Laurence J
‡9
2
|
950
|
|
|
‡a
direk kenan
‡A
Direk, Kenan
‡9
2
|
950
|
|
|
‡a
virani salim s
‡A
Virani, Salim S
‡9
2
|
950
|
|
|
‡a
kaminski karol a
‡A
Kaminski, Karol A
‡9
2
|
950
|
|
|
‡a
muehlschlegel jochen d
‡A
Muehlschlegel, Jochen D
‡9
2
|
950
|
|
|
‡a
dube marie pierre
‡A
Dube, Marie-Pierre
‡9
2
|
950
|
|
|
‡a
almgren peter
‡A
Almgren, Peter
‡9
2
|
950
|
|
|
‡a
alver maris
‡A
Alver, Maris
‡9
2
|
950
|
|
|
‡a
baranova ekaterina
‡A
Baranova, Ekaterina
‡9
2
|
950
|
|
|
‡a
boeckx bram
‡A
Boeckx, Bram
‡9
2
|
950
|
|
|
‡a
braund peter s
‡A
Braund, Peter S
‡9
2
|
950
|
|
|
‡a
breitling lutz p
‡A
Breitling, Lutz P
‡9
2
|
950
|
|
|
‡a
duarte nubia e
‡A
Duarte, Nubia E
‡9
2
|
950
|
|
|
‡a
dufresne line
‡A
Dufresne, Line
‡9
2
|
950
|
|
|
‡a
hartiala jaana
‡A
Hartiala, Jaana
‡9
2
|
950
|
|
|
‡a
heydarpour mahyar
‡A
Heydarpour, Mahyar
‡9
2
|
950
|
|
|
‡a
hubacek jaroslav a
‡A
Hubacek, Jaroslav A
‡9
2
|
950
|
|
|
‡a
kleber marcus
‡A
Kleber, Marcus
‡9
2
|
950
|
|
|
‡a
kofink daniel
‡A
Kofink, Daniel
‡9
2
|
950
|
|
|
‡a
lee vei vei
‡A
Lee, Vei-Vei
‡9
2
|
950
|
|
|
‡a
lenzini petra a
‡A
Lenzini, Petra A
‡9
2
|
950
|
|
|
‡a
levin daniel
‡A
Levin, Daniel
‡9
2
|
950
|
|
|
‡a
martinelli nicola
‡A
Martinelli, Nicola
‡9
2
|
950
|
|
|
‡a
mons ute
‡A
Mons, Ute
‡9
2
|
950
|
|
|
‡a
nelson christopher p
‡A
Nelson, Christopher P
‡9
2
|
950
|
|
|
‡a
pilbrow anna p
‡A
Pilbrow, Anna P
‡9
2
|
950
|
|
|
‡a
ploski rafal
‡A
Ploski, Rafal
‡9
2
|
950
|
|
|
‡a
sun yan
‡A
Sun, Yan
‡9
2
|
950
|
|
|
‡a
tanck michael w t
‡A
Tanck, Michael W. T
‡9
2
|
950
|
|
|
‡a
vilmundarson ragnar o
‡A
Vilmundarson, Ragnar O
‡9
2
|
950
|
|
|
‡a
anselmi chiara viviani
‡A
Anselmi, Chiara Viviani
‡9
2
|
950
|
|
|
‡a
vlachopoulou efthymia
‡A
Vlachopoulou, Efthymia
‡9
2
|
950
|
|
|
‡a
boerwinkle eric
‡A
Boerwinkle, Eric
‡9
2
|
950
|
|
|
‡a
briguori carlo
‡A
Briguori, Carlo
‡9
2
|
950
|
|
|
‡a
carlquist john f
‡A
Carlquist, John F
‡9
2
|
950
|
|
|
‡a
carruthers kathryn f
‡A
Carruthers, Kathryn F
‡9
2
|
950
|
|
|
‡a
van der harst pim
‡A
Van der Harst, Pim
‡9
2
|
950
|
|
|
‡a
deloukas panos
‡A
Deloukas, Panos
‡9
2
|
950
|
|
|
‡a
dudbridge frank
‡A
Dudbridge, Frank
‡9
2
|
950
|
|
|
‡a
fitzpatrick natalie
‡A
Fitzpatrick, Natalie
‡9
2
|
950
|
|
|
‡a
lokki marja liisa
‡A
Lokki, Marja-Liisa
‡9
2
|
950
|
|
|
‡a
lotufo paulo a
‡A
Lotufo, Paulo A
‡9
2
|
950
|
|
|
‡a
muhlestein joseph b
‡A
Muhlestein, Joseph B
‡9
2
|
950
|
|
|
‡a
pitha jan
‡A
Pitha, Jan
‡9
2
|
950
|
|
|
‡a
samman tahhan ayman
‡A
Samman-Tahhan, Ayman
‡9
2
|
950
|
|
|
‡a
sandesara pratik b
‡A
Sandesara, Pratik B
‡9
2
|
950
|
|
|
‡a
teren andrej
‡A
Teren, Andrej
‡9
2
|
950
|
|
|
‡a
timmis adam
‡A
Timmis, Adam
‡9
2
|
950
|
|
|
‡a
van de werf frans
‡A
Van de Werf, Frans
‡9
2
|
950
|
|
|
‡a
wauters els
‡A
Wauters, Els
‡9
2
|
950
|
|
|
‡a
wilde arthur a m
‡A
Wilde, Arthur A. M
‡9
2
|
950
|
|
|
‡a
ford ian
‡A
Ford, Ian
‡9
2
|
950
|
|
|
‡a
stott david j
‡A
Stott, David J
‡9
2
|
950
|
|
|
‡a
andreassi maria g
‡A
Andreassi, Maria G
‡9
2
|
950
|
|
|
‡a
ardissino diego
‡A
Ardissino, Diego
‡9
2
|
950
|
|
|
‡a
arsenault benoit j
‡A
Arsenault, Benoit J
‡9
2
|
950
|
|
|
‡a
ballantyne christie m
‡A
Ballantyne, Christie M
‡9
2
|
950
|
|
|
‡a
bergmeijer thomas o
‡A
Bergmeijer, Thomas O
‡9
2
|
950
|
|
|
‡a
bezzina connie r
‡A
Bezzina, Connie R
‡9
2
|
950
|
|
|
‡a
body simon c
‡A
Body, Simon C
‡9
2
|
950
|
|
|
‡a
bogaty peter
‡A
Bogaty, Peter
‡9
2
|
950
|
|
|
‡a
brenner hermann
‡A
Brenner, Hermann
‡9
2
|
950
|
|
|
‡a
carpeggiani clara
‡A
Carpeggiani, Clara
‡9
2
|
950
|
|
|
‡a
condorelli gianluigi
‡A
Condorelli, Gianluigi
‡9
2
|
950
|
|
|
‡a
engert james c
‡A
Engert, James C
‡9
2
|
950
|
|
|
‡a
girelli domenico
‡A
Girelli, Domenico
‡9
2
|
950
|
|
|
‡a
hemingway harry
‡A
Hemingway, Harry
‡9
2
|
950
|
|
|
‡a
hoefer imo e
‡A
Hoefer, Imo E
‡9
2
|
950
|
|
|
‡a
hovingh g kees
‡A
Hovingh, G. Kees
‡9
2
|
950
|
|
|
‡a
kaczor marcin p
‡A
Kaczor, Marcin P
‡9
2
|
950
|
|
|
‡a
kettner jiri
‡A
Kettner, Jiri
‡9
2
|
950
|
|
|
‡a
kiliszek marek
‡A
Kiliszek, Marek
‡9
2
|
950
|
|
|
‡a
klungel olaf h
‡A
Klungel, Olaf H
‡9
2
|
950
|
|
|
‡a
lambrechts diether
‡A
Lambrechts, Diether
‡9
2
|
950
|
|
|
‡a
lindholm daniel
‡A
Lindholm, Daniel,
‡d
1982
‡9
2
|
950
|
|
|
‡a
mcpherson ruth
‡A
McPherson, Ruth
‡9
2
|
950
|
|
|
‡a
melander olle
‡A
Melander, Olle
‡9
2
|
950
|
|
|
‡a
metspalu andres
‡A
Metspalu, Andres
‡9
2
|
950
|
|
|
‡a
olivieri oliviero
‡A
Olivieri, Oliviero
‡9
2
|
950
|
|
|
‡a
opolski grzegorz
‡A
Opolski, Grzegorz
‡9
2
|
950
|
|
|
‡a
palmer colin n
‡A
Palmer, Colin N
‡9
2
|
950
|
|
|
‡a
pasterkamp gerard
‡A
Pasterkamp, Gerard
‡9
2
|
950
|
|
|
‡a
pereira alexandre c
‡A
Pereira, Alexandre C
‡9
2
|
950
|
|
|
‡a
quyyumi arshed a
‡A
Quyyumi, Arshed A
‡9
2
|
950
|
|
|
‡a
richards a mark
‡A
Richards, A. Mark
‡9
2
|
950
|
|
|
‡a
sanak marek
‡A
Sanak, Marek
‡9
2
|
950
|
|
|
‡a
smith j gustav
‡A
Smith, J. Gustav
‡9
2
|
950
|
|
|
‡a
stewart alexandre f r
‡A
Stewart, Alexandre F. R
‡9
2
|
950
|
|
|
‡a
szczeklik wojciech
‡A
Szczeklik, Wojciech
‡9
2
|
950
|
|
|
‡a
szpakowicz anna
‡A
Szpakowicz, Anna
‡9
2
|
950
|
|
|
‡a
thanassoulis george
‡A
Thanassoulis, George
‡9
2
|
950
|
|
|
‡a
van der graaf yolanda
‡A
Van der Graaf, Yolanda
‡9
2
|
950
|
|
|
‡a
visseren frank l j
‡A
Visseren, Frank L. J
‡9
2
|
950
|
|
|
‡a
hingorani aroon d
‡A
Hingorani, Aroon D
‡9
2
|
950
|
|
|
‡a
samani nilesh j
‡A
Samani, Nilesh J
‡9
2
|
950
|
|
|
‡a
andersson emelie
‡A
Andersson, Emelie
‡9
2
|
950
|
|
|
‡a
engstrom thomas
‡A
Engstrom, Thomas.
‡9
2
|
950
|
|
|
‡a
persson jonas
‡A
Persson, Jonas.
‡9
2
|
950
|
|
|
‡a
bergman sofia
‡A
Bergman, Sofia.
‡9
2
|
950
|
|
|
‡a
leosdottir margret
‡A
Leosdottir, Margret.
‡9
2
|
950
|
|
|
‡a
grimfjard per
‡A
Grimfjärd, Per,
‡d
1975-
‡9
2
|
950
|
|
|
‡a
meijer karina
‡A
Meijer, Karina.
‡9
2
|
950
|
|
|
‡a
li hao
‡A
Li, Hao.
‡9
2
|
950
|
|
|
‡a
pan yuesong
‡A
Pan, Yuesong.
‡9
2
|
950
|
|
|
‡a
capodanno davide
‡A
Capodanno, Davide.
‡9
2
|
950
|
|
|
‡a
mehran roxana
‡A
Mehran, Roxana.
‡9
2
|
950
|
|
|
‡a
wedin johan o
‡A
Wedin, Johan O.
‡9
2
|
950
|
|
|
‡a
grinnemo karl henrik
‡A
Grinnemo, Karl-Henrik.
‡9
2
|
950
|
|
|
‡a
smekal david
‡A
Smekal, David,
‡d
1971-
‡9
2
|
950
|
|
|
‡a
ghukasyan tatevik
‡A
Ghukasyan, Tatevik.
‡9
2
|
950
|
|
|
‡a
di somma salvatore
‡A
Di Somma, Salvatore.
‡9
2
|
950
|
|
|
‡a
specchia giuseppe
‡A
Specchia, Giuseppe.
‡9
2
|
950
|
|
|
‡a
gasior mariusz
‡A
Gasior, Mariusz.
‡9
2
|
950
|
|
|
‡a
tycinska agnieszka
‡A
Tycinska, Agnieszka.
‡9
2
|
950
|
|
|
‡a
wojakowski wojciech
‡A
Wojakowski, Wojciech.
‡9
2
|
950
|
|
|
‡a
buszko katarzyna
‡A
Buszko, Katarzyna.
‡9
2
|
950
|
|
|
‡a
gil robert
‡A
Gil, Robert.
‡9
2
|
950
|
|
|
‡a
gruchala marcin
‡A
Gruchala, Marcin.
‡9
2
|
950
|
|
|
‡a
dudek dariusz
‡A
Dudek, Dariusz.
‡9
2
|
950
|
|
|
‡a
gurbel paul a
‡A
Gurbel, Paul A.
‡9
2
|
950
|
|
|
‡a
kleinrok andrzej
‡A
Kleinrok, Andrzej.
‡9
2
|
950
|
|
|
‡a
legutko jacek
‡A
Legutko, Jacek.
‡9
2
|
950
|
|
|
‡a
lesiak maciej
‡A
Lesiak, Maciej.
‡9
2
|
950
|
|
|
‡a
jaguszewski milosz j
‡A
Jaguszewski, Milosz J.
‡9
2
|
950
|
|
|
‡a
navarese eliano p
‡A
Navarese, Eliano P.
‡9
2
|
950
|
|
|
‡a
kubica jacek
‡A
Kubica, Jacek.
‡9
2
|
950
|
|
|
‡a
adamski piotr
‡A
Adamski, Piotr.
‡9
2
|
950
|
|
|
‡a
gorog diana a
‡A
Gorog, Diana A.
‡9
2
|
950
|
|
|
‡a
siller matula jolanta m
‡A
Siller-Matula, Jolanta M.
‡9
2
|
950
|
|
|
‡a
niezgoda piotr
‡A
Niezgoda, Piotr.
‡9
2
|
950
|
|
|
‡a
kubica aldona
‡A
Kubica, Aldona.
‡9
2
|
950
|
|
|
‡a
jilma bernd
‡A
Jilma, Bernd.
‡9
2
|
950
|
|
|
‡a
badariene jolita
‡A
Badariene, Jolita.
‡9
2
|
950
|
|
|
‡a
alexopoulos dimitrios
‡A
Alexopoulos, Dimitrios.
‡9
2
|
950
|
|
|
‡a
jeong young hoon
‡A
Jeong, Young-Hoon.
‡9
2
|
950
|
|
|
‡a
simon tabassome
‡A
Simon, Tabassome.
‡9
2
|
950
|
|
|
‡a
tank amarjeet
‡A
Tank, Amarjeet.
‡9
2
|
950
|
|
|
‡a
mellstrom carl
‡A
Mellström, Carl.
‡9
2
|
950
|
|
|
‡a
bhatt deepak l
‡A
Bhatt, Deepak L.
‡9
2
|
950
|
|
|
‡a
redfors bjorn
‡A
Redfors, Bjorn.
‡9
2
|
950
|
|
|
‡a
ono masafumi
‡A
Ono, Masafumi.
‡9
2
|
950
|
|
|
‡a
hara hironori
‡A
Hara, Hironori.
‡9
2
|
950
|
|
|
‡a
gao chao
‡A
Gao, Chao.
‡9
2
|
950
|
|
|
‡a
serruys patrick w
‡A
Serruys, Patrick W.
‡9
2
|
951
|
|
|
‡a
uppsala universitet medicinska och farmaceutiska vetenskapsomradet
‡A
Uppsala universitet
‡b
Medicinska och farmaceutiska vetenskapsområdet.
‡9
67
|
951
|
|
|
‡a
ucr
‡A
UCR.
‡9
6
|
951
|
|
|
‡a
kardiologi
‡A
Kardiologi.
‡9
4
|
951
|
|
|
‡a
uppsala universitet science for life laboratory scilifelab
‡A
Uppsala universitet
‡b
Science for Life Laboratory, SciLifeLab.
‡9
2
|
996
|
|
|
‡2
BNF|16693446
|
996
|
|
|
‡2
PTBNP|1592379
|
996
|
|
|
‡2
CAOONL|ncf11435095
|
996
|
|
|
‡2
LC|no2009012909
|
996
|
|
|
‡2
J9U|987007329625705171
|
996
|
|
|
‡2
LC|n 80053380
|
996
|
|
|
‡2
NTA|131303201
|
996
|
|
|
‡2
NUKAT|n 2010135884
|
996
|
|
|
‡2
BNF|15012563
|
996
|
|
|
‡2
LC|nb2019009171
|
996
|
|
|
‡2
LC|n 2012059167
|
996
|
|
|
‡2
ISNI|0000000459660329
|
996
|
|
|
‡2
LC|n 2020030246
|
996
|
|
|
‡2
SUDOC|254602622
|
996
|
|
|
‡2
ISNI|0000000500250736
|
996
|
|
|
‡2
DBC|87097992241637
|
996
|
|
|
‡2
ISNI|0000000067778889
|
996
|
|
|
‡2
ISNI|0000000049211547
|
996
|
|
|
‡2
BIBSYS|8056627
|
996
|
|
|
‡2
ISNI|0000000138956698
|
996
|
|
|
‡2
WKP|Q64868663
|
996
|
|
|
‡2
DNB|1257986082
|
996
|
|
|
‡2
BIBSYS|90564676
|
996
|
|
|
‡2
BIBSYS|11042607
|
996
|
|
|
‡2
SUDOC|17031345X
|
996
|
|
|
‡2
SUDOC|156658453
|
996
|
|
|
‡2
WKP|Q3526952
|
996
|
|
|
‡2
NLA|000035636799
|
996
|
|
|
‡2
J9U|987007376599505171
|
996
|
|
|
‡2
LC|no 95029578
|
996
|
|
|
‡2
WKP|Q92714052
|
996
|
|
|
‡2
WKP|Q19874701
|
996
|
|
|
‡2
LC|n 94021181
|
996
|
|
|
‡2
LC|no2023088413
|
996
|
|
|
‡2
NTA|406865418
|
996
|
|
|
‡2
BIBSYS|98014232
|
996
|
|
|
‡2
NUKAT|n 00078544
|
996
|
|
|
‡2
LC|n 92089483
|
996
|
|
|
‡2
DNB|1261759451
|
996
|
|
|
‡2
BNCHL|10000000000000000185168
|
996
|
|
|
‡2
LC|n 2002010554
|
996
|
|
|
‡2
LC|no2022091403
|
996
|
|
|
‡2
DNB|143158678
|
996
|
|
|
‡2
BIBSYS|14021482
|
996
|
|
|
‡2
NTA|303201290
|
996
|
|
|
‡2
ISNI|0000000037305319
|
996
|
|
|
‡2
BNF|14534974
|
996
|
|
|
‡2
ISNI|0000000026765512
|
996
|
|
|
‡2
ISNI|0000000074472423
|
996
|
|
|
‡2
ISNI|0000000495491200
|
996
|
|
|
‡2
LC|n 82209319
|
996
|
|
|
‡2
KRNLK|KAC200504279
|
996
|
|
|
‡2
LC|no2015126709
|
996
|
|
|
‡2
W2Z|1634286306017
|
996
|
|
|
‡2
ISNI|0000000119928229
|
996
|
|
|
‡2
PTBNP|1409267
|
996
|
|
|
‡2
LC|n 2009184860
|
996
|
|
|
‡2
LC|nb2023014689
|
996
|
|
|
‡2
BIBSYS|1634286306017
|
996
|
|
|
‡2
N6I|vtls002664160
|
996
|
|
|
‡2
WKP|Q89326053
|
996
|
|
|
‡2
ISNI|0000000043756829
|
996
|
|
|
‡2
SUDOC|149999372
|
996
|
|
|
‡2
DNB|134906705
|
996
|
|
|
‡2
LC|nb 99042685
|
996
|
|
|
‡2
WKP|Q89702325
|
996
|
|
|
‡2
BIBSYS|1671433162352
|
996
|
|
|
‡2
NTA|297963082
|
996
|
|
|
‡2
NTA|155615696
|
996
|
|
|
‡2
CAOONL|ncf10539879
|
996
|
|
|
‡2
SUDOC|109578244
|
996
|
|
|
‡2
LC|n 82055974
|
996
|
|
|
‡2
LC|n 91087660
|
996
|
|
|
‡2
BIBSYS|90937099
|
996
|
|
|
‡2
BNF|12278859
|
996
|
|
|
‡2
NSK|000703666
|
996
|
|
|
‡2
WKP|Q130889970
|
996
|
|
|
‡2
ISNI|0000000025753923
|
996
|
|
|
‡2
SUDOC|113309309
|
996
|
|
|
‡2
LC|no2019055946
|
996
|
|
|
‡2
CAOONL|ncf11280134
|
996
|
|
|
‡2
LC|no2008153197
|
996
|
|
|
‡2
LC|no2004111950
|
996
|
|
|
‡2
BNF|14189932
|
996
|
|
|
‡2
NTA|143781618
|
996
|
|
|
‡2
CAOONL|ncf10415537
|
996
|
|
|
‡2
LC|n 84135340
|
996
|
|
|
‡2
J9U|987007449517105171
|
996
|
|
|
‡2
LC|n 80024201
|
996
|
|
|
‡2
WKP|Q79846130
|
996
|
|
|
‡2
WKP|Q1798956
|
996
|
|
|
‡2
NTA|407357238
|
996
|
|
|
‡2
CAOONL|ncf10080163
|
996
|
|
|
‡2
LC|n 95056922
|
996
|
|
|
‡2
LNB|LNC10-000054417
|
996
|
|
|
‡2
ISNI|0000000497026193
|
996
|
|
|
‡2
LC|n 98097564
|
996
|
|
|
‡2
LC|nb2007018907
|
996
|
|
|
‡2
WKP|Q7614877
|
996
|
|
|
‡2
ISNI|0000000108487560
|
996
|
|
|
‡2
BIBSYS|90066729
|
996
|
|
|
‡2
LC|no2014047676
|
996
|
|
|
‡2
DNB|1221981064
|
996
|
|
|
‡2
ISNI|0000000035210260
|
996
|
|
|
‡2
NII|DA10963948
|
996
|
|
|
‡2
NII|DA06783443
|
996
|
|
|
‡2
DNB|1176033379
|
996
|
|
|
‡2
J9U|987007391027005171
|
996
|
|
|
‡2
DNB|1053151705
|
996
|
|
|
‡2
ISNI|0000000032662691
|
996
|
|
|
‡2
LC|no2019154965
|
996
|
|
|
‡2
BNF|17057699
|
996
|
|
|
‡2
BIBSYS|1051612
|
996
|
|
|
‡2
LC|n 84082125
|
996
|
|
|
‡2
DNB|142489298
|
997
|
|
|
‡a
1964 0 lived 0 0
‡9
1
|
998
|
|
|
‡a
James, Steve
‡2
SUDOC|183947673
‡3
joint author: (0.70, 'ross stephanie', 'james stephanie')
|
998
|
|
|
‡a
James, Stephen J.
‡2
ISNI|0000000117672856
‡3
joint author: (0.77, 'james c', 'engert james c')
|
998
|
|
|
‡a
James, S.J.
‡2
ISNI|0000000117672856
‡3
joint author: (0.77, 'james c', 'engert james c')
|
998
|
|
|
‡a
James, S. J.
‡2
ISNI|0000000117672856
‡3
joint author: (0.77, 'james c', 'engert james c')
|
998
|
|
|
‡a
James, Stefan,
‡2
ISNI|0000000051845223
‡3
partial date, publisher
‡3
suggested
‡3
single date
|
998
|
|
|
‡a
James, Stefan
‡2
ISNI|0000000051845223
‡3
partial date, publisher
‡3
suggested
‡3
single date
|
998
|
|
|
‡a
James, Stefan
‡2
ISNI|0000000051845223
‡3
partial date, publisher
‡3
suggested
‡3
single date
|
998
|
|
|
‡a
James, S.
‡2
ISNI|0000000051845223
‡3
partial date, publisher
‡3
suggested
‡3
single date
|
998
|
|
|
‡a
James, Stefan
‡2
PLWABN|9810647093105606
‡3
joint author: (1.00, 'vranckx pascal', 'vranckx pascal')
‡3
viafid
|
998
|
|
|
‡a
Stefan James
‡c
researcher
‡2
WKP|Q86735199
‡3
exact title: (1.00, 'prevalenceandrelevanceofabnormalglucosemetabolisminacutecoronarysyndromesinsightsfromtheplateletinhibitionandpatientoutcomesplatotrial', 'prevalenceandrelevanceofabnormalglucosemetabolisminacutecoronarysyndromesinsightsfromtheplateletinhibitionandpatientoutcomesplatotrial')
|
998
|
|
|
‡a
James, S.J.
‡2
BIBSYS|2060600
‡3
joint author: (0.77, 'james c', 'engert james c')
|
999
|
|
|
‡2
SWEBIB|1398320608
|
999
|
|
|
‡2
SWEBIB|1401081580
|
999
|
|
|
‡2
SWEBIB|1417019485
|
999
|
|
|
‡2
SWEBIB|1038678524
|
999
|
|
|
‡2
SWEBIB|1143813506
|
999
|
|
|
‡2
SWEBIB|1280448194
|
999
|
|
|
‡2
SWEBIB|1105745575
|
999
|
|
|
‡2
SWEBIB|1253121355
|
999
|
|
|
‡2
SWEBIB|1243294672
|
999
|
|
|
‡2
SWEBIB|1455663843
|
999
|
|
|
‡2
SWEBIB|1293045008
|
999
|
|
|
‡2
SWEBIB|1401081053
|
999
|
|
|
‡2
SWEBIB|1340929636
|
999
|
|
|
‡2
SWEBIB|1377507445
|
999
|
|
|
‡2
SWEBIB|1156369398
|
999
|
|
|
‡2
SWEBIB|1272090331
|
999
|
|
|
‡2
SWEBIB|1239957786
|
999
|
|
|
‡2
SWEBIB|1270968478
|
999
|
|
|
‡2
SWEBIB|1370532758
|
999
|
|
|
‡2
SWEBIB|1233257842
|
999
|
|
|
‡2
SWEBIB|1104798662
|
999
|
|
|
‡2
SWEBIB|186566794
|
999
|
|
|
‡2
SWEBIB|1153500687
|
999
|
|
|
‡2
SWEBIB|1394147054
|
999
|
|
|
‡2
SWEBIB|1360437207
|
999
|
|
|
‡2
SWEBIB|1412638627
|
999
|
|
|
‡2
SWEBIB|1101730183
|
999
|
|
|
‡2
SWEBIB|1240385819
|
999
|
|
|
‡2
SWEBIB|1281948671
|
999
|
|
|
‡2
SWEBIB|1143542616
|
999
|
|
|
‡2
SWEBIB|1184458979
|
999
|
|
|
‡2
SWEBIB|1428919863
|
999
|
|
|
‡2
SWEBIB|1127106980
|
999
|
|
|
‡2
SWEBIB|1298370477
|
999
|
|
|
‡2
SWEBIB|1239959529
|
999
|
|
|
‡2
SWEBIB|1434753993
|
999
|
|
|
‡2
SWEBIB|1223007763
|
999
|
|
|
‡2
SWEBIB|1279343160
|
999
|
|
|
‡2
SWEBIB|1292433705
|
999
|
|
|
‡2
SWEBIB|1101731439
|
999
|
|
|
‡2
SWEBIB|1255159357
|
999
|
|
|
‡2
SWEBIB|1455806874
|
999
|
|
|
‡2
SWEBIB|1395577346
|
999
|
|
|
‡2
SWEBIB|1324228566
|
999
|
|
|
‡2
SWEBIB|1313063197
|
999
|
|
|
‡2
SWEBIB|1273744532
|
999
|
|
|
‡2
SWEBIB|1131902917
|
999
|
|
|
‡2
SWEBIB|1158252639
|
999
|
|
|
‡2
SWEBIB|1309004284
|
999
|
|
|
‡2
SWEBIB|1342123897
|
999
|
|
|
‡2
SWEBIB|1355111068
|
999
|
|
|
‡2
SWEBIB|1104797493
|
999
|
|
|
‡2
SWEBIB|1227443080
|
999
|
|
|
‡2
SWEBIB|1381029315
|
999
|
|
|
‡2
SWEBIB|1340928565
|
999
|
|
|
‡2
SWEBIB|1155495090
|
999
|
|
|
‡2
SWEBIB|1259634499
|
999
|
|
|
‡2
SWEBIB|1356128144
|
999
|
|
|
‡2
SWEBIB|1305391391
|
999
|
|
|
‡2
SWEBIB|1287969981
|
999
|
|
|
‡2
SWEBIB|1452264304
|
999
|
|
|
‡2
SWEBIB|1129177667
|
999
|
|
|
‡2
SWEBIB|1146221705
|
999
|
|
|
‡2
SWEBIB|1225171764
|
999
|
|
|
‡2
SWEBIB|1408765271
|
999
|
|
|
‡2
SWEBIB|1270968450
|
999
|
|
|
‡2
SWEBIB|1308783941
|
999
|
|
|
‡2
SWEBIB|1305962994
|